MAPK3 and benign prostatic hyperplasia: In conclusion, the results of the obtained studies will provide novel data on the relationship between miRNAs 106a‐5p and 375‐3p with the proteins ERK1/2, p38, β‐catenin and E‐cadherin in prostate cancer compared to BPH.